Importance of Myocardial Fibrosis in Functional Mitral Regurgitation | Zendy

Bernardo B.C. Lopes | Zendy; Deborah Kwon | Zendy; Dipan J. Shah | Zendy; John R. Lesser | Zendy; Vinayak Bapat | Zendy; Maurice EnriquezSarano | Zendy; Paul Sorajja | Zendy; João L. Cavalcante | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Importance of Myocardial Fibrosis in Functional Mitral Regurgitation

Author(s) -

Bernardo B.C. Lopes,

Deborah Kwon,

Dipan J. Shah,

John R. Lesser,

Vinayak Bapat,

Maurice EnriquezSarano,

Paul Sorajja,

João L. Cavalcante

Publication year - 2021

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2020.10.027

Subject(s) - cardiology , risk stratification , functional mitral regurgitation , medicine , myocardial fibrosis , mitral regurgitation , cardiac magnetic resonance , fibrosis , magnetic resonance imaging , heart failure , radiology , ejection fraction

Functional mitral regurgitation (FMR) is a common and complex valve disease, in which severity and risk stratification is still a conundrum. Although risk increases with FMR severity, it is modulated by subjacent left ventricular (LV) disease. The extent of LV remodeling and dysfunction is traditionally evaluated by echocardiography, but a growing body of evidence shows that myocardial fibrosis (MF) assessment by cardiac magnetic resonance (CMR) may complement risk stratification and inform treatment decisions. This review summarizes the current knowledge on the comprehensive evaluation that CMR can provide for patients with FMR, in particular for the assessment of MF and its potential impact in clinical decision-making.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research